Abiopharma

🔍 RAAB MICHAEL (Director)

Company: ARDELYX, INC. (ARDX)

Report Date: 2025-08-21

Detailed Transactions and Holdings:

• Sold 45,687 shares of Common Stock at $5.9317 per share (Direct)
  Date: 2025-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,502,250.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: Family Trust | shares_owned_after: 24,364.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: Family Trust | shares_owned_after: 1,000.00 | Footnotes: F3

Footnotes:

• F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
• F2: The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
• F3: The shares are owned directly by trusts for the benefit of the Reporting Person's children.